Familial steroid-resistant nephrotic syndrome with sensorineural deafness

Familial steroid-resistant nephrotic syndrome with sensorineural deafness is an extremely rare genetic disorder characterized by the combination of nephrotic syndrome that does not respond to corticosteroid therapy and sensorineural hearing loss. Nephrotic syndrome is a kidney condition marked by heavy proteinuria (excessive protein loss in the urine), hypoalbuminemia (low blood albumin levels), edema (swelling, particularly in the legs and around the eyes), and hyperlipidemia (elevated blood lipid levels). In this familial form, the kidney disease is resistant to standard steroid treatment, which distinguishes it from more common forms of childhood nephrotic syndrome. The sensorineural deafness component indicates damage to the inner ear or auditory nerve pathways, leading to varying degrees of hearing impairment. The condition primarily affects two body systems: the kidneys and the auditory system. The renal disease can progress to focal segmental glomerulosclerosis (FSGS) and may ultimately lead to end-stage renal disease requiring dialysis or kidney transplantation. Because the nephrotic syndrome is steroid-resistant, treatment options are limited and may include alternative immunosuppressive agents such as calcineurin inhibitors (cyclosporine or tacrolimus), though responses are variable. Management of the hearing loss typically involves hearing aids or cochlear implants depending on severity. Supportive care for the nephrotic syndrome includes dietary modifications, management of edema with diuretics, and control of hyperlipidemia. Given the familial nature of this condition, genetic counseling is recommended for affected families. The underlying genetic basis has been linked to mutations affecting podocyte function and inner ear structures, though the precise molecular mechanisms remain under investigation.

Common questions about Familial steroid-resistant nephrotic syndrome with sensorineural deafness